Loperamide

This classification denotes an opioid and antidiarrheal agent with the molecular formula C29H33ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6X9OC3H4II, chemically known as 4-(4-chlorophenyl)-n,n-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide but generally known as loperamide, which bears US NIH Compound Identifier 3955. European Medicines Agency schedules Loperamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08572MIG. The term LOPERAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules loperamide in its Anatomical Therapeutic Chemical (ATC) Classification. LOPERAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule loperamide under HS 29333999 and SITC 51574. As of Q4 2014, LOPERAMIDE remains the US FDA Preferred Term for this commodity. Loperamide bears US NLM identifiers UMLS ID C0023992 and NCI Concept Code C618. SMILES: CLC1CCC(C2(O)CCN(CC2)CCC(C2CCCCC2)(C2CCCCC2)C(=O)N(C)C)CC1.